endogenous retrovirus group FRD member 1, envelope
RGD ID:
1563240
Description:
Predicted to be involved in syncytium formation by plasma membrane fusion. Predicted to act upstream of or within labyrinthine layer development and myoblast fusion. Predicted to be located in membrane. Orthologous to human ERVFRD-1 (endogenous retrovirus group FRD member 1, envelope); INTERACTS WITH 3,7-dihydropurine-6-thione; 6-propyl-2-thiouracil; bisphenol A.
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Benzo(a)pyrene results in increased expression of ERVFRD-1 mRNA] more ...
[Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [Colforsin results in increased expression of ERVFRD-1 mRNA] and [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ERVFRD-1 mRNA
[Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [Colforsin results in increased expression of ERVFRD-1 mRNA] and [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ERVFRD-1 mRNA
[Cadmium Chloride results in increased abundance of Cadmium] inhibits the reaction [Colforsin results in increased expression of ERVFRD-1 mRNA] more ...
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA
[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SYNA mRNA